MARC Record from Library of Congress

LEADER: 02846cam a22004577a 4500
001 2011397160
003 DLC
005 20111016080724.0
008 110401s2010 sz a b i000 0 eng
010 $a 2011397160
016 7 $a101519579$2DNLM
016 7 $a015792577$2Uk
020 $a9789241563888
020 $a9241563885
035 $a(OCoLC)ocn704937550
040 $aNLM$cNLM$dBGU$dOUN$dTPH$dHPH$dYDXCP$dINU$dUKMGB$dDLC
042 $anlmcopyc$alccopycat
050 00 $aRG137$b.M43 2010
060 00 $a2011 C-918
060 10 $aHQ 766
082 04 $a363.96$222
245 00 $aMedical eligibility criteria for contraceptive use /$cWorld Health Organization.
250 $a4th ed.
260 $aGeneva :$bDepartment of Reproductive Health and Research, World Health Organization,$c2010.
300 $a125 p. :$bill. ;$c30 cm.
500 $a"A WHO family planning cornerstone."
504 $aIncludes bibliographical references.
520 8 $aThis document reviews the medical eligibility criteria for use of contraception, offering guidance on the safety of use of different methods for women and men with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research. It is a companion guideline to 'Selected Practice Recommendations for Contraceptive Use'. Together, these documents are intended to be used by policy-makers, programme managers, and the scientific community, to support national programmes in the preparation of service delivery guidelines.
505 00 $gMachine generated contents note:$tCombined hormonal contraceptives (CHCs) (combined oral contraceptives, combined injectable contraceptives, patch, ring) --$tProgestogen-only contraceptives (POCs) --$tEmergency contraceptive pills (ECPs) --$tIntrauterine devices (IUDs) --$tCopper IUD for emergency contraception (E-IUD) --$tBarrier methods (BARR) --$tFertility awareness-based methods (FAB) --$tLactational amenorrhoea method (LAM) --$tCoitus interruptus (CI) --$tSurgical sterilization procedures (STER) --$tFemale surgical sterilization --$tMale surgical sterilization --$tSummary tables (SUMM) --$tAnnexes --$gAnnex 1$tHormonal contraceptives and antiretroviral therapies.
650 0 $aContraceptives$xPhysiological effect$xEvaluation.
650 0 $aContraceptive drugs$xSide effects.
650 0 $aDrug interactions.
650 0 $aDiseases$xRisk factors.
650 0 $aHealth risk assessment.
650 0 $aContraception$xComplications$xPrevention.
650 12 $aFamily Planning Services.
650 22 $aContraception$xcontraindications.
650 22 $aContraception$xmethods.
650 22 $aEligibility Determination$xstandards.
650 22 $aHealth Services Accessibility.
710 2 $aWorld Health Organization.$bReproductive Health and Research.